Skip to content

Apotheek Xavier Ameloot

Active
Private limited companyfounded 2005active for 21 yearsGrote Markt 23, 8970 Poperinge, BelgiumKBO/BCE: BE 0872.659.609
Summary

Apotheek Xavier Ameloot has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €726,691 and a net result of €99,125. Equity has been growing by about 16% per year since 2019. Its solvency ranks better than 52% of 12,777 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Official details

Source: KBO
Status
Active since 22-03-2005 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 30-09-2024
Establishment unit
2.145.978.807 8970 Poperinge, since 01-04-2005
Financial year end
30 September
Peppol
Reachable since 31-08-2023

Board and ownership

Board
  • TOPDirector · permanent representative TOP Eveliene
Shareholders
  • TOP· score 672025 annual accounts of TOP

Financial position

86 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Annual accounts to 30-09-2025
Gross margin
€419,421
▲ 23.2%
Turnover
≈ €1.5m
estimated
Profit
€99,125
▲ 13.2%
Equity
€726,691
▲ 15.8%
Total assets
€1.9m
▲ 12.0%
Employees on 30-09-2025
4
=
Score breakdownraises riskLiquidity: current ratio 2.23, cash €5,281, halvedSector: Retail trade (NACE 47)lowers riskFounded in 2005Size: total assets €1.9mShow the evidence

Checked score

Score 2025
86 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 52% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Average
Solvency 63+1
equity 38.0% of total assets
Liquidity 36+9
short-term debt 32.8% · cash 0.3%
Profitability 71-4
return on assets 5.2%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.3%lowest value 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.4%▲ +0.1 percentage points vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.7%▲ +0.3 percentage points vs 03-2026highest value 05-2026: 0.3%▼ -0.4 percentage points vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026 11-2026: 0.3%● unchanged vs 10-2026
Credit of up to €60,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.23 (1.62 in 2024), above the usual 1.5. Short-term debt is 32.8% and cash 0.3% of total assets. However, 62% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 53% of them on solvency, 33% on liquidity, 53% on profitability and 68% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 2.23, cash €5,281, halved
NBB · annual accounts
lowers risk · Founded in 2005
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Size: total assets €1.9m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 30-04-2026, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
42 days early
2023
106 days early
2022
17 days early
2021
86 days early
2020
35 days early
2019
71 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 51 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 19 March (4 of the last 5 accounts filed within 44 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end03-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: More equity than 80% of companies in retail tradesector median €236,633 · 12,787 companies €726,691 View
  • Positive: 7 profitable years in a rowprofit 2025: €99,125 7 years View

Recent changes

  1. · Gazette deed Company renamed from Apotheek Xavier Ameloot bvba to Apotheek Xavier AmelootChange of role: TOP, from manager to director · Permanent representative: TOP Eveliene
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as Apotheek Xavier Ameloot: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.8m and €2.4m, founded between 2002 and 2006.

CompanyTotal assetsGross margin
Apotheek Xavier Ameloot Poperinge€1.9m€0.4m
APOTHEKERS BEKE-DEBUSSCHERE Deerlijk€1.8m€0.4m
APOTHEEK DEFEVER Liedekerke€2.1m€0.4m
Het Apothekershuis Bree€1.8m€0.4m
PHARMACIE SMITS Wavre€1.9m€0.4m
APOTHEEK BLINDEMAN Beveren-Kruibeke-Zwijndrecht€2.0m€0.4m
Apotheek De Kerselaar Harelbeke Harelbeke€2.4m€0.4m
Full comparison

Key facts about Apotheek Xavier Ameloot

What is the company number of Apotheek Xavier Ameloot?
The company number of Apotheek Xavier Ameloot is 0872.659.609. The VAT number is the same number with BE in front: BE 0872.659.609.
Where is Apotheek Xavier Ameloot based?
The registered office is at Grote Markt 23, 8970 Poperinge.Company details
What does Apotheek Xavier Ameloot do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Xavier Ameloot?
The legal form of Apotheek Xavier Ameloot is Private limited company (BV).
When was Apotheek Xavier Ameloot founded?
Apotheek Xavier Ameloot was founded on 22-03-2005.
Is Apotheek Xavier Ameloot still active?
Yes, Apotheek Xavier Ameloot is an active enterprise in the KBO register.
How many employees does Apotheek Xavier Ameloot have?
Apotheek Xavier Ameloot had an average of 3.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Apotheek Xavier Ameloot fall under?
In its 30-09-2024 annual accounts, Apotheek Xavier Ameloot states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of Apotheek Xavier Ameloot?
The turnover in financial year 2025 is ≈ €1.5m. This figure is estimated from the gross margin of €419,421 and 47 comparable companies (NACE 477). It probably lies between €1.2m and €2.5m.
Is Apotheek Xavier Ameloot profitable?
In financial year 2025, Apotheek Xavier Ameloot made a profit of €99,125.
Where can I find the annual accounts of Apotheek Xavier Ameloot?
Apotheek Xavier Ameloot filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Xavier Ameloot due?
Apotheek Xavier Ameloot must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.